EASD 2019: The GLP-1 Agonist PEX168 Improves Glycemic Control, Both With and Without Metformin
The safety profile was favorable.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
The safety profile was favorable.
Only registered members have full access to PracticeUpdate content.